Physician profile
Donna Shepard
NPI 1043209612
$1,577.91
in general payments reported to CMS, 2019-2025
9 companies · $416 in 2025
The $416 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $438 · 2020: $65.15 · 2021: $239 · 2022: $90.25 · 2023: $47.36 · 2024: $283 · 2025: $416.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $746.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $745.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Visioneering Technologies, INC. | $363.42 | 2019-2025 | |
| Johnson & Johnson Vision Care, INC. | $352.11 | 2019-2025 | |
| Alcon Vision LLC | $263.73 | 2019-2024 | Total30, Precision 1 |
| Biotissue Holdings INC. | $212.74 | 2021-2023 | |
| Tarsus Pharmaceuticals, INC. | $137.07 | 2024 | |
| Novartis Pharmaceuticals Corporation | $119.78 | 2021 | |
| Synergeyes, INC. | $53.58 | 2019 | |
| Rxsight INC | $38.65 | 2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens |
| Coopervision INC. | $36.83 | 2025 | Myday Contact Lens |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donna Shepard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.